GnRH Agonist statistics

Simon Tegg made this Official Information request to Pharmaceutical Management Agency

The request was successful.

From: Simon Tegg

Dear Pharmac,

In response to a previous OIA request dated 28th August 2023 Pharmac supplied statistics on the number of patients (PREVALENCE) dispensed of GnRH agonists broken down by
- YEAR: 2006 - 2022, CALENDAR year.
- AGE: 0-17 by year, supplemented by the 12-17 age category.
- SEX: M, F

Thankyou for your timely response. I make the same request however this time updated to be the years: 2006 - 2023.

IN ADDITION I request INCIDENCE data broken down by the same year, age, and sex categories. To clarify by "incidence" I mean the number of patients who start on GnRH agonist treatment the age and sex categories in a calendar year who were not dispensed GnRH agonist the previous calendar year.

Yours faithfully,

Simon Tegg

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Kia ora Simon

Thank you for your request for information, received by Pharmac on 5 February 2024. Your request has been received and logged. Our reference number for your request is: 2023-24-115.

As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 6 March 2024.

If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.

Please feel free to contact us if you require any further assistance.

Ngâ mihi,

Katy Carlson (she/her) | Government Services Advisor
___________________________________________________________________
Te Pâtaka Whaioranga – Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: 0800 660 050 |http://www.pharmac.govt.nz/

-----Original Message-----
From: Simon Tegg <[FOI #25632 email]>
Sent: Monday, 5 February 2024 9:27 pm
To: Web Enquiry <[email address]>
Subject: Official Information request - GnRH Agonist statistics

[You don't often get email from [FOI #25632 email]. Learn why this is important at https://aka.ms/LearnAboutSenderIdentific... ]

Dear Pharmac,

In response to a previous OIA request dated 28th August 2023 Pharmac supplied statistics on the number of patients (PREVALENCE) dispensed of GnRH agonists broken down by
- YEAR: 2006 - 2022, CALENDAR year.
- AGE: 0-17 by year, supplemented by the 12-17 age category.
- SEX: M, F

Thankyou for your timely response. I make the same request however this time updated to be the years: 2006 - 2023.

IN ADDITION I request INCIDENCE data broken down by the same year, age, and sex categories. To clarify by "incidence" I mean the number of patients who start on GnRH agonist treatment the age and sex categories in a calendar year who were not dispensed GnRH agonist the previous calendar year.

Yours faithfully,

Simon Tegg

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #25632 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2024 02 GnRH Agonist statistics.xlsx
26K Download View as HTML

Attachment 2023 24 115 2024 03 01 Response letter Official Information request GnRH Agonist statistics.pdf
144K Download View as HTML


Kia ora Simon

Please find a response to your request attached to this email.

Ngâ mihi,

Katy Carlson (she/her) | Government Services Advisor
___________________________________________________________________
Te Pâtaka Whaioranga – Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: 0800 660 050 |http://www.pharmac.govt.nz/

-----Original Message-----
From: Simon Tegg <[FOI #25632 email]>
Sent: Monday, February 5, 2024 9:27 PM
To: Web Enquiry <[email address]>
Subject: Official Information request - GnRH Agonist statistics

[You don't often get email from [FOI #25632 email]. Learn why this is important at https://aka.ms/LearnAboutSenderIdentific... ]

Dear Pharmac,

In response to a previous OIA request dated 28th August 2023 Pharmac supplied statistics on the number of patients (PREVALENCE) dispensed of GnRH agonists broken down by
- YEAR: 2006 - 2022, CALENDAR year.
- AGE: 0-17 by year, supplemented by the 12-17 age category.
- SEX: M, F

Thankyou for your timely response. I make the same request however this time updated to be the years: 2006 - 2023.

IN ADDITION I request INCIDENCE data broken down by the same year, age, and sex categories. To clarify by "incidence" I mean the number of patients who start on GnRH agonist treatment the age and sex categories in a calendar year who were not dispensed GnRH agonist the previous calendar year.

Yours faithfully,

Simon Tegg

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #25632 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: